1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)

Detalles Bibliográficos
Autores principales: Mohanlal, R., Ogenstad, S., Huang, L., Blayney, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454421/
http://dx.doi.org/10.1016/j.annonc.2021.08.1680
_version_ 1784570491166523392
author Mohanlal, R.
Ogenstad, S.
Huang, L.
Blayney, D.
author_facet Mohanlal, R.
Ogenstad, S.
Huang, L.
Blayney, D.
author_sort Mohanlal, R.
collection PubMed
description
format Online
Article
Text
id pubmed-8454421
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84544212021-09-21 1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN) Mohanlal, R. Ogenstad, S. Huang, L. Blayney, D. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454421/ http://dx.doi.org/10.1016/j.annonc.2021.08.1680 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mohanlal, R.
Ogenstad, S.
Huang, L.
Blayney, D.
1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
title 1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
title_full 1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
title_fullStr 1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
title_full_unstemmed 1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
title_short 1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
title_sort 1708p severe neutropenia (grade 4, gr4n) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (cin)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454421/
http://dx.doi.org/10.1016/j.annonc.2021.08.1680
work_keys_str_mv AT mohanlalr 1708psevereneutropeniagrade4gr4nasapopulationbasedpredictorforadverseclinicaloutcomeofchemotherapyinducedneutropeniacin
AT ogenstads 1708psevereneutropeniagrade4gr4nasapopulationbasedpredictorforadverseclinicaloutcomeofchemotherapyinducedneutropeniacin
AT huangl 1708psevereneutropeniagrade4gr4nasapopulationbasedpredictorforadverseclinicaloutcomeofchemotherapyinducedneutropeniacin
AT blayneyd 1708psevereneutropeniagrade4gr4nasapopulationbasedpredictorforadverseclinicaloutcomeofchemotherapyinducedneutropeniacin

Ejemplares similares